No Data
No Data
Hokuriku Pharmaceutical (300016.SZ): Jiuwei Zhenxin granules are the first pure traditional Chinese medicine preparation approved in China to treat generalized anxiety disorder
Gelonghui, April 22丨Hokuriku Pharmaceutical (300016.SZ) said on the investor interactive platform that Jiuwei Zhenxin granules are the first pure Chinese medicine formulation approved in China to treat generalized anxiety disorder. In order to improve patients' medication experience and improve patient compliance, the company is developing new prescriptions containing flavoring agents. The new flavor Jiuwei Zhenxin granules will be marketed and sold after approval by the corresponding drug regulatory authorities to better meet the medication needs of patients.
Hokuriku Pharmaceutical (300016.SZ) announced first-quarter results, net profit of 11.526,200 yuan, a decrease of 8.35%
Hokuriku Pharmaceutical (300016.SZ) released its report for the first quarter of 2024. The company's revenue was 2.08...
Hokuriku Pharmaceutical (300016.SZ) announced its 2023 annual results, changing profit to loss to 71.7571 million yuan
Hokuriku Pharmaceutical (300016.SZ) released its 2023 annual report. The company's revenue was 891 million yuan...
Hokuriku Pharmaceutical (300016.SZ) plans to spend 202 million yuan to acquire 80% of Tianyuan Pharmaceutical's shares to further implement the strategic layout in the field of proprietary Chinese medicine
Hokuriku Pharmaceutical (300016.SZ) announced that the company plans to acquire Jin'an Guoji with its own capital of RMB 202 million...
Express News | Hokuriku Pharmaceutical: Plans to acquire 80% of Tianyuan Pharmaceutical's shares for 200 million yuan
Hokuriku Pharmaceutical (300016.SZ): Currently, no relevant personnel training plans have been signed with universities
Gelonghui, April 12 | Hokuriku Pharmaceutical (300016.SZ) said on the investor interactive platform that at present, the company has not signed relevant talent training plans with colleges, but we attach great importance to cooperation and exchanges with universities to cultivate and introduce outstanding talents through school-enterprise internship base cooperation, etc. The company has established school-enterprise internship base partnerships with Hebei Medical University since 2019 and Shenyang Pharmaceutical University since 2020.
No Data